Jianshe Wang Selected Research

perfluoro-3,5,7,9,11-pentaoxadodecanoic acid

1/2021

Chronic exposure to PFO4DA and PFO5DoDA, two perfluoroalkyl ether carboxylic acids (PFECAs), suppresses hepatic stress signals and disturbs glucose and lipid metabolism in male mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianshe Wang Research Topics

Disease

6	Neoplasms (Cancer) 01/2018 - 04/2008
3	Body Weight (Weight, Body) 01/2021 - 09/2008
3	Hepatomegaly 12/2020 - 01/2015
2	Liver Diseases (Liver Disease) 01/2022 - 07/2015
2	Cholestasis 01/2021 - 12/2015
2	Hyperglycemia 01/2021 - 11/2017
2	Infections 12/2020 - 10/2002
2	Inflammation (Inflammations) 11/2018 - 01/2010
2	Nasopharyngeal Carcinoma 11/2018 - 01/2015
2	Hypothyroidism 11/2018 - 12/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 11/2016
2	Hepatitis B 12/2002 - 10/2002
1	Epstein-Barr Virus Infections 01/2022
1	Cough 01/2022
1	Fever (Fevers) 01/2022
1	Exanthema (Rash) 01/2022
1	Weight Gain 01/2021
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 12/2020
1	Hypoglycemia (Reactive Hypoglycemia) 12/2020
1	Metabolic Diseases (Metabolic Disease) 11/2017
1	Pelvic Organ Prolapse 05/2017
1	Lung Neoplasms (Lung Cancer) 04/2017
1	Pneumothorax 04/2017
1	Infarction (Infarctions) 01/2017
1	Ischemia 01/2017
1	Tyrosinemias (Tyrosinemia) 01/2016
1	Iron Overload 01/2016
1	Nutrition Disorders (Nutritional Disorders) 01/2016
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 09/2011
1	Animal Diseases 09/2011
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 06/2011
1	Chronic Hepatitis B 12/2002

Drug/Important Bio-Agent (IBA)

3	Transaminases (Aminotransferases)IBA 01/2022 - 01/2015
3	perfluorooctanoic acidIBA 11/2017 - 04/2008
3	AcidsIBA 06/2017 - 06/2011
3	Hormones (Hormone)IBA 01/2017 - 12/2015
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 07/2015
2	CarbonIBA 06/2017 - 01/2015
2	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 12/2002 - 10/2002
2	Immunoglobulins (Immunoglobulin)IBA 12/2002 - 10/2002
1	EnzymesIBA 01/2022
1	tetrahydrobenzo-4,6-dimethylangelicinIBA 01/2021
1	perfluoro-3,5,7,9,11-pentaoxadodecanoic acidIBA 01/2021
1	AntibodiesIBA 12/2020
1	C-Reactive ProteinIBA 11/2018
1	Calcium Gluconate (CBG)IBA 01/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2017
1	Glucagon (Glukagon)FDA Link 11/2017
1	Progesterone FDA LinkGeneric 06/2017
1	Extracellular Matrix ProteinsIBA 05/2017
1	Iodine-125IBA 04/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017
1	myricetinIBA 01/2017
1	Radiation-Sensitizing AgentsIBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 11/2016
1	IronIBA 01/2016
1	MetalsIBA 01/2016
1	Tyrosine (L-Tyrosine)FDA Link 01/2016
1	HepcidinsIBA 01/2016
1	Phospholipid Transfer ProteinsIBA 12/2015
1	Adenosine Triphosphatases (ATPase)IBA 12/2015
1	Adenosine Triphosphate (ATP)IBA 12/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2015
1	Oxidoreductases (Dehydrogenase)IBA 07/2015
1	CholesterolIBA 01/2015
1	perfluoro-n-nonanoic acidIBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	MycotoxinsIBA 09/2011
1	T-2 Toxin (T 2 Toxin)IBA 09/2011
1	Amino Acids FDA Link 06/2011
1	Adenosine (Adenocard)FDA LinkGeneric 04/2010
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2010
1	Caspase 8 (Caspase-8)IBA 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010
1	Caspase 3 (Caspase-3)IBA 01/2010
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2010
1	ApolipoproteinsIBA 01/2010
1	LipidsIBA 01/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2002
1	hepatitis B hyperimmune globulinIBA 12/2002
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2002

Therapy/Procedure

3	Radiotherapy 01/2017 - 01/2015
2	Therapeutics 04/2017 - 12/2002
1	Aftercare (After-Treatment) 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2018
1	Drug Therapy (Chemotherapy) 04/2017
1	Brachytherapy 04/2017
1	Chemoradiotherapy 01/2015
1	Intraperitoneal Injections 09/2008